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AbstrAct
Objective
To examine the dose-response associations between 
accelerometer assessed total physical activity, 
different intensities of physical activity, and sedentary 
time and all cause mortality.
Design
Systematic review and harmonised meta-analysis.
Data sOurces
PubMed, PsycINFO, Embase, Web of Science, Sport 
Discus from inception to 31 July 2018.
eligibility criteria
Prospective cohort studies assessing physical activity 
and sedentary time by accelerometry and associations 
with all cause mortality and reported effect estimates 
as hazard ratios, odds ratios, or relative risks with 
95% confidence intervals.
Data extractiOn anD analysis
Guidelines for meta-analyses and systematic reviews 
for observational studies and PRISMA guidelines 
were followed. Two authors independently screened 
the titles and abstracts. One author performed a 
full text review and another extracted the data. Two 
authors independently assessed the risk of bias. 
Individual level participant data were harmonised 
and analysed at study level. Data on physical activity 
were categorised by quarters at study level, and study 
specific associations with all cause mortality were 
analysed using Cox proportional hazards regression 
analyses. Study specific results were summarised 
using random effects meta-analysis.
Main OutcOMe Measure
All cause mortality.
results
39 studies were retrieved for full text review; 10 were 
eligible for inclusion, three were excluded owing to 
harmonisation challenges (eg, wrist placement of the 
accelerometer), and one study did not participate. 
Two additional studies with unpublished mortality 
data were also included. Thus, individual level data 
from eight studies (n=36 383; mean age 62.6 years; 
72.8% women), with median follow-up of 5.8 years 
(range 3.0-14.5 years) and 2149 (5.9%) deaths 
were analysed. Any physical activity, regardless of 
intensity, was associated with lower risk of mortality, 
with a non-linear dose-response. Hazards ratios for 
mortality were 1.00 (referent) in the first quarter (least 
active), 0.48 (95% confidence interval 0.43 to 0.54) 
in the second quarter, 0.34 (0.26 to 0.45) in the third 
quarter, and 0.27 (0.23 to 0.32) in the fourth quarter 
(most active). Corresponding hazards ratios for light 
physical activity were 1.00, 0.60 (0.54 to 0.68), 
0.44 (0.38 to 0.51), and 0.38 (0.28 to 0.51), and for 
moderate-to-vigorous physical activity were 1.00, 0.64 
(0.55 to 0.74), 0.55 (0.40 to 0.74), and 0.52 (0.43 to 
0.61). For sedentary time, hazards ratios were 1.00 
(referent; least sedentary), 1.28 (1.09 to 1.51), 1.71 
(1.36 to 2.15), and 2.63 (1.94 to 3.56).
cOnclusiOn
Higher levels of total physical activity, at any intensity, 
and less time spent sedentary, are associated with 
substantially reduced risk for premature mortality, 
with evidence of a non-linear dose-response pattern 
in middle aged and older adults.
systeMatic review registratiOn
PROSPERO CRD42018091808.
Introduction
Physical inactivity is associated with many chronic 
diseases,1 premature mortality,2 and substantial 
economic burden.3 Increasing evidence also suggests 
that high levels of time spent sedentary might increase 
the risk of chronic diseases and mortality.4 5
The current evidence on the associations between 
physical activity or sedentary time and health outcomes 
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WhAt Is AlreAdy knoWn on thIs topIc
Physical inactivity is associated with many chronic diseases and premature 
mortality and increasing evidence also suggests that high levels of sedentary 
time may increase the risk of chronic diseases and mortality
Current physical activity guidelines are, however, informed primarily by self 
reported physical activity studies, which are susceptible to error
Thus the magnitude of associations is likely underestimated and the shape of 
dose-response relations, particularly for light intensity activity, is unclear
WhAt thIs study Adds
All intensities of physical activity, including light intensity, are associated with a 
substantially reduced risk of death in a dose-response manner
The observed effect sizes for the associations between physical activity and the 
risk of death are about twice as large compared with those previously reported in 
studies assessing physical activity by self report
A statistical significantly higher risk of death was observed for sedentary times of 
9.5 or more hours daily
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are primarily from studies that used participant 
self reported physical activity and sedentary time.1 
Self reports are, however, prone to recall and social 
desirability biases, which result in over-estimation of 
physical activity,6 7 are usually restricted to a limited 
number of physical activity domains (eg, leisure 
time activity), underestimate sedentary time,8 and 
rarely provide data on total physical activity and light 
physical activity.7 Furthermore, the magnitude of the 
association between physical activity and mortality 
is likely underestimated, as a result of imprecision in 
exposure measurements, whereas the shape of the 
dose-response associations for light intensity physical 
activity is unclear. Indeed, the US Physical Activity 
Guidelines advisory committee recently indicated the 
impact of total physical activity and light intensity 
physical activity for reducing mortality risk as a priority 
for research.1
To reduce the biases associated with self report, 
several recent cohort studies have used device 
based methods (ie, accelerometry) when examining 
associations between physical activity or sedentary 
time and mortality.9-13 However, the results are 
inconsistent, even when derived from the same 
dataset.13 14 This is related to differences in analytical 
methods. Also, most of these studies are statistically 
underpowered to examine the associations between 
dose-response and intensity specific physical activity 
and mortality because of their relatively short follow-
up time and few deaths.
We conducted a harmonised meta-analysis to exa-
mine the association between accelerometer measured 
physical activity and sedentary time and all cause 
mortality. Specifically, we examined the dose-response 
relations of total physical activity, different intensities 
of physical activity (light, low light, high light, 
moderate to vigorous, and vigorous) and sedentary 
time and all cause mortality.
Methods
We conducted a systematic review following the 
guidelines for Meta-Analyses and Systematic reviews for 
Observational Studies15 and the PRISMA guidelines.16 
The review protocol is registered with the PROSPERO 
database (CRD42018091808).
Data sources
We performed a systematic search in five databases 
(PubMed, PsycINFO, Embase, Web of Science, Sport 
Discus) from inception of the database to 31 July 2018. 
When searching for eligible articles we used the search 
terms (“physical activity” or “physical activities” or 
“physically active” or “physical exercise” or “exercise” 
or “walk” and “mortality” or “mortalities” or” death 
“or “fatal” or “accelerometer” or “activity monitor” or 
“motion sensor” or “device-based” or “Actigraph” or 
“Actical” or “Sensewear” or “Actiband” or “Actiwatch”). 
Forward and backwards tracking was performed by 
examining the reference list of studies potentially 
eligible for inclusion.
study selection
Two authors (UE, JSS) independently screened the 
titles and abstracts. After exclusion of duplicates, one 
author (JSS) performed a full text review, and the final 
list of studies was discussed among the writing group. 
Inclusion criteria were prospective cohort studies 
that assessed sedentary time and physical activity by 
accelerometry, had data on individual level exposure 
and all cause mortality, reported effect estimates as 
hazard ratios, odds ratios, or relative risks with 95% 
confidence intervals for all cause mortality, and were 
published in English or Scandinavian. Owing to the 
noticeable variations in output from accelerometers 
placed at different body sites,17 which precludes 
harmonisation of physical activity data, we excluded 
three studies18-20 in which physical activity was 
assessed by monitors placed on the upper arm, wrist, 
and thigh. On author request one eligible study was 
not included in the harmonised meta-analysis.11
Data extraction
One author (UE) extracted the following information 
from each eligible study: name of first author, 
study location, and number of participants, age of 
participants, number of each sex, years of follow-up, 
number of deaths from all causes, methods of case 
ascertainment, assessment details for physical activity 
and sedentary time, and covariates included in final, 
adjusted models. Another author (JSS) cross checked 
data extraction variables.
risk of bias
Using the Newcastle Ottawa quality assessment scale,21 
two authors (UE, JT) independently assessed the 
studies and resolved disagreements by consensus. This 
semiquantitative scale uses a star system to assess the 
quality for eight items across three domains (selection, 
comparability, and exposure), with a maximum of one 
star for each item for high quality studies except for the 
comparability domain (two stars). Thus the total score 
ranges from 0 to 9. Supplementary table 2 provides 
further details of the quality rating.
Data synthesis and harmonisation of exposure 
variables
We contacted the corresponding author from each of 
the identified studies and asked whether he or she 
would be willing to contribute to a harmonised meta-
analysis. To reduce heterogeneity in data cleaning 
and processing of accelerometer data among studies, 
authors of the studies reprocessed their individual 
participant data according to our standardised protocol. 
Data from the vertical acceleration axis in 60 second 
epochs were extracted, and we defined non-wear time 
as 90 consecutive minutes of 0 counts per minute (cpm), 
allowing up to a two minute interval of non-zero cpm 
if the interruption was accompanied by 30 consecutive 
minutes of 0 cpm either upstream or downstream.22 We 
included all participants who recorded a wear time of 10 
or more hours each day for four or more days.23
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Each study computed several exposure variables 
from accelerometer measurements: total volume of 
physical activity (total counts/wear time in minutes, 
cpm); time (min/day) spent in six intensity specific 
variables (sedentary, ≤100 cpm,24 light, 101-1951 
cpm,25 low light, 101-759 cpm,13 high light, 760-1951 
cpm,13 moderate to vigorous, ≥1952 cpm,25 vigorous, 
≥5725cpm25; bouts of moderate-to-vigorous intensity 
physical activity, defined as 10 or more minutes 
of consecutive accelerometer readings ≥1952 cpm 
allowing for 1-2 minute drops below the threshold 
during each period of 10 or more minutes. For two 
studies9 26 that assessed physical activity using the 
Actical accelerometer, the same wear time criteria as 
previously described were used and physical activity 
intensity thresholds computed according to previous 
validation studies27 28: sedentary, ≤100 cpm; light, 
101-1534 cpm; low light, 101-599 cpm; high light, 
600-1534 cpm; moderate to vigorous >1535 cpm; and 
vigorous ≥3960 cpm.
analyses
Participating studies conducted several study specific 
analyses to examine the associations between 
exposure variables with all cause mortality using Cox 
proportional hazards regression analyses (hazard 
ratios and 95% confidence intervals) restricted 
to participants aged 40 or more years. Exposure 
data were categorised into quarters, with the first 
quarter (least active) as referent. Associations 
between physical activity variables with mortality 
were analysed with several levels of adjustment: 
model A (adjusting for wear time (except cpm, as 
wear time is included in this calculation), sex (if 
applicable), and age); model B (model A+adjustment 
for socioeconomic status and body mass index 
(BMI) and mutual adjustment of sedentary time and 
moderate-to-vigorous-intensity physical activity); 
and model C (model B+adjustment for covariates 
included in the study’s final adjusted model, as listed 
in table 1). Mortality data from two studies9 12 were 
updated from their publication follow-up before 
analyses. Owing to different data processing criteria 
the numbers of participants and deaths slightly differ 
from those previously published. Before the analyses, 
we accounted for the sample weights and complex 
survey design of the National Health and Nutrition 
Examination Survey (NHANES).29
Individual study summary data were meta-analysed 
with a random effects model yielding three pooled 
hazard ratios with 95% confidence intervals (first 
quarter as referent versus second to fourth quarters) in 
each model. We used model B as our primary model. 
For two variables, moderate-to-vigorous intensity 
physical activity in bouts and vigorous intensity 
physical activity, we included all participants who 
recorded zero minutes in the referent group, and we 
categorised the remaining participants into thirds.
Based on the individual studies log transformed 
hazard ratios for each of the quarters in model B, we 
described the underlying dose-response associations 
with sedentary time, total physical activity, and 
intensity specific activity using a restricted cubic 
spline model to allow for potential non-linearity.30 We 
prespecified three knots at the 25th, 50th, and 75th 
centiles of the exposure variable distributions using 
the medians of the quarters to define the exposure 
levels (supplementary table 8, and see fig 2). We 
accounted for non-zero referent groups by centring 
the exposure levels.31 Departure from linearity 
was assessed by a Wald test examining the null 
hypothesis that the coefficient of the second spline 
was equal to zero.32 Model fit was examined visually 
using de-correlated residuals-versus-exposure plots 
and by the coefficient of determination.33 Data from 
two studies that assessed physical activity by the 
Actical accelerometer9 26 were only included for time 
spent in moderate-to-vigorous intensity physical 
activity for the dose-response analyses because of the 
noticeable difference in absolute output for the other 
exposure variables compared with the Actigraph 
accelerometer.34
In sensitivity analyses, we excluded deaths within 
the first two years of follow-up and reanalysed the 
data according to model B. We reanalysed data 
for total physical activity (cpm) excluding the two 
studies9 26 in which physical activity was measured 
by a different type of accelerometer than used in the 
other studies. We also reanalysed the data excluding 
the two studies in which data on the association 
between physical activity and mortality had not been 
previously published.26 35 We reanalysed our data 
and estimated summary hazard ratios across studies 
with fixed effects inverse variance method, and the 
main findings were unchanged (data not shown). We 
assessed heterogeneity by I2 statistics. Finally, to assess 
possible publication bias we created funnel plots for 
the individual study hazard ratios, comparing extreme 
exposure quarters and calculated the Egger’s test for 
funnel plot symmetry. Meta-analyses were performed 
using Matlab (R2014a, Mathworks, Natick, MA).
Patient and public involvement
No patients were involved in the planning, design, or 
research idea for this systematic review. Nor were they 
involved in the analyses or data collection for the work. 
We did not evaluate whether the individual studies 
included in the review had any patient involvement. 
The results from the present study will be disseminated 
through the institutional websites and press releases.
results
Overall, 39 of 518 identified articles were retrieved for 
full text review. Ten were eligible for inclusion, three 
were excluded owing to harmonisation challenges 
(ie. monitor placements), and one study did not 
participate, leaving six for inclusion (fig 1).9 10 12 13 36 37 
Data were publicly available from one of the identified 
studies13 and data were obtained from a further two 
studies with pertinent data available.26 35
Thus individual level data from eight studies, of 
which three were from nationally representative 
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surveillance systems10 13 35 including 36 383 partici-
pants (mean age 62.6 years; 72.8% women) with a 
median follow-up time of 5.8 years (mean 6.7 years, 
range 3.0-14.5 years, 243 766 person years) were 
included in the meta-analyses. During follow-up, 2149 
(5.9%) participants died. Table 1 summarises the 
characteristics of studies (participant characteristics 
by study are presented in supplementary table 1). 
The quality scores were high, at 8 or 9 (table 1 and 
supplementary table 2).
Compared with the referent, any level of physical 
activity regardless of intensity was associated with 
a substantially lower risk of mortality (table 2, 
supplementary figs 1a-f). The magnitude of lowered 
risk was most pronounced for total physical activity; 
hazard ratios (95% confidence intervals) for increasing 
quarter were: 1.00 (referent, least active), 0.48 (0.43 to 
0.54), 0.34 (0.26 to 0.45), and 0.27 (0.23 to 0.32) (table 
2, model B, supplementary fig 1a). Higher levels of light 
intensity physical activity, as well as low and high light 
intensity physical activity were also associated with 
substantially reduced risks of death during follow-up. 
The risk reductions were most pronounced when the 
second quarter was compared against the referent for 
all levels of adjustment (table 2, fig 2). For example, the 
risk was reduced to 0.55 (0.49 to 0.63) in the second 
quarter for high light intensity physical activity and 
additionally reduced in the third (0.38, 0.30 to 0.48) 
and fourth (0.37, 0.32 to 0.46) quarters compared 
with the referent (table 2, model B). Higher levels of 
moderate-to-vigorous intensity physical activity were 
also associated with a reduced risk of death even after 
table 1 | characteristics of studies included in the meta-analysis
Publication
study; location; no 
of participants; no 
of cases
year of baseline 
assessment; 
mean follow-up
case  
ascertainment
accelerometer 
type (location) covariates
Quality  
assessment*
Bakrania et al36 Walking Away from 
Type 2 Diabetes 
(WAT2D), England; 
n=654 (411 men, 
243 women); 26 
cases
2010-11; 5.7 
years
Office for National 
Statistics
Actigraph GT3X+ 
(right hip)
Age, sex, BMI, socioeconomic status 8
Diaz et al9 Reasons for Geo-
graphic and Racial 
Differences in Stroke 
(REGARDS); US; 
n=7862 (3580 men; 
4282 women); 590 
cases
2003-07; 5.3 
years
Review of death 
certificates, medical 
records, and  
administrative 
databases
Actical (right hip) Age, sex, BMI, education, race, region of  
residence, season the accelerometer was 
worn, current smoking, alcohol use, diabetes,  
hypertension, dyslipidemia, estimated 
glomerular filtration rate, atrial fibrillation, 
history of coronary heart disease, and history 
of stroke
9
Dohrn et al10 Sweden Attitude 
Behaviour and 
Change study (ABC), 
Sweden; n=834 (371 
men, 463 women); 
79 cases
2001-02; 14.5 
years
National death 
register
Actigraph 7164 
(lower back)
Age, sex, education, BMI, smoking, history 
of hypertension, heart disease, cancer, and 
diabetes
9
Jefferis et al37 British Regional Heart 
Study (BRHS), UK; 
n=1412 men; 250 
cases
2010-12; 6.0 
years
National Health  
Service central 
registers
Actigraph GT3X+ 
(right hip)
Age, BMI, Social class, season of accel-
erometer wear, region of residence, lives 
alone / with others, alcohol, smoking, sleep, 
locomotor disability, previous MI, stroke or 
heart failure
9
Lee et al12 Women’s Health 
Study (WHS), US; 
n=16738, women; 
n=504
2011-17; 4.3 
years
Medical records, 
death certificates, 
or National Death 
Index
Actigraph GT3X+ 
(right hip)
Age, income, BMI, smoking; alcohol; intakes 
of saturated fat, fibre, fruits, and vegetables; 
hormone therapy; parental history of  
myocardial infarction; family history of  
cancer; general health; history of  
cardiovascular disease; history of cancer; and 
cancer screening
9
Unpublished data  
(Murabito et al26)
Framingham Heart 
Study (FHS), US; 
n=2621 (1225 men, 
1396 women); 77 
cases
2008-11; 4.0 
years
Medical records, 
death certificates
Actical (right hip) Age, sex, education, BMI, ethnicity, smoking, 
self reported health
9
NHANES13 (data downloaded 
from wwwn.cdc.gov/nchs/
nhanes/Default.aspx and  
Public-use Linked Mortality 
data†
National Health and 
Nutrition Examination 
Survey (NHANES), 
US;(n=3978 (1977 
men, 2001 women); 
492 cases
2003-06; 6.5 
years
National Death 
Index, National 
Center for Health 
Statistics
Actigraph 7164 
(right hip)
Age, socioeconomic status, BMI, ethnicity, 
smoking, alcohol, mobility limitations,  
number of medical conditions (diabetes,  
congestive heart failure, coronary heart 
disease, angina pectoris, heart attack, stroke, 
cancer)
9
Unpublished data  
(Hansen et al35)
Norwegian National 
Physical Activity 
Survey 1 (NNPAS), 
Norway; n=2284; 
131 cases
2008-09; 8.9 
years
Death certificates, 
Norwegian death 
register
Actigraph GT1M 
(right hip)
Age, sex, education, BMI, wear time, smoking, 
alcohol, number of medical conditions
9
BMI=body mass index.
*Quality assessment according to Newcastle-Ottawa scale (range 0-9) for cohort studies (see supplementary material for further details).
†National Center for Health Statistics. Office of Analysis and Epidemiology, Public-use Linked Mortality File, 2015. Hyattsville, MD, USA (www.cdc.gov/nchs/data_access/data_linkage/mortality.
htm).
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adjustment for sedentary time (table 2, models B and C; 
fig 2). The risk of death increased with increasing time 
spent sedentary; hazard ratios for increasing quarters 
were: 1.00 (referent), 1.28 (1.09 to 1.51), 1.71 (1.36 
to 2.15), and 2.63 (1.94 to 3.56) after adjustment for 
age, sex, BMI, socioeconomic status, wear time, and 
time spent in moderate-to-vigorous intensity physical 
activity (table 2, models B and C; fig 2).
The differences in physical activity and sedentary 
time (min/day) between the referent and the second 
quarter were broadly equal to 60 min/day of light 
intensity physical activity, 35 min/day of low light 
intensity physical activity, 25 min/day of high light 
intensity physical activity, 5 min/day of moderate-to-
vigorous intensity physical activity, and 70 min/day of 
sedentary time (supplementary table 3).
Higher levels of bouts of moderate-to-vigorous 
intensity physical activity and any vigorous intensity 
physical activity were also associated with reduced risk 
of mortality (supplementary table 4). However, low 
numbers of participants undertook physical activity in 
bouts of moderate-to-vigorous physical activity or in 
any vigorous physical activity (supplementary table 4), 
potentially making these estimates less reliable.
We observed non-linear, dose-response associations 
(P values from the second spline <0.02 for each 
exposure variable) for the associations between all 
exposure variables and mortality (fig 2, supplementary 
table 5). The maximal risk reduction for total physical 
activity (hazard ratio 0.34, 95% confidence interval 
0.27 to 0.43) was observed at about 300 cpm. Maximal 
risk reductions for light intensity physical activity 
(0.48, 0.38 to 0.63), low light intensity physical 
activity (0.45, 0.34 to 0.60), high light intensity 
physical activity (0.40, 0.31 to 0.52), and moderate-to-
vigorous intensity physical activity (0.39, 0.26 to 0.59) 
were observed at about 375 min/day, 325 min/day, 
80 min/day, and 24 min/day, respectively. No further 
risk reductions occurred with higher levels of activity 
except for low light intensity physical activity where 
the risk appeared to decrease further (supplementary 
table 5).
The dose-response relations between sedentary time 
and mortality increased gradually from about 7.5 to 9 
hours and were more pronounced at greater than 9.5 
hours (fig 2, supplementary table 5). Ten and 12 hours 
each day spent sedentary were associated with 1.48 
(1.22 to 1.79) and 2.92 (2.24 to 3.83) higher risk of 
death, respectively.
The results did not appreciably change when 
excluding deaths within the first two years of follow-
up, except for a small attenuation for the association 
between sedentary time and mortality (supplementary 
table 6). Similarly, sensitivity analyses excluding the 
two studies in which physical activity was assessed 
by a different monitor did not change the results 
(supplementary table 7). There was no evidence 
of publication bias; however, the plots should be 
interpreted cautiously owing to the small number of 
studies (supplementary figs 2 and 3).
discussion
Higher levels of total physical activity at any intensity 
and less time spent sedentary are associated with a 
substantially reduced risk for premature mortality, 
with evidence of a non-linear dose-response pattern 
in middle aged and older adults. Our observations 
on the associations between accelerometry measured 
physical activity or sedentary time and all cause 
mortality provide important data for informing public 
health recommendations. Firstly, they reinforce 
the non-linear, dose-response relation but with 
considerably larger effect sizes than in studies using 
self reports. Secondly, the total volume of physical 
activity, irrespective of intensity, is associated with a 
substantially reduced risk of death during follow-up. 
Thirdly, the greatest risk reduction for mortality was 
observed when the second quarter was compared 
with the referent, for all activity intensities. Fourthly, 
maximal risk reductions were seen at about 375 min/
day of light intensity physical activity or 24 min/day 
of moderate-to-vigorous intensity physical activity. 
Fifthly, a statistically significantly higher risk of death 
was observed from 9.5 or more hours per day for time 
spent sedentary.
Records identified through database search and retrieved
Excluded based on full text
Secondary analysis
No outcome on mortality
  reported
28
1
Duplicates removed
Records retained for title and abstract review
313
Records assessed by full text for eligibility
Studies eligible for inclusion
10
518
205
Excluded based on
title and abstract
274
Unpublished studies identified
through personal contact
39
29
Excluded
Study refused to participate
Additional studies excluded
  owing to harmonisation
  issues
1
3
Studies contacted and included in harmonised meta-analyses
2
4
8
Fig 1 | study selection
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strengths and limitations of this study
Our meta-analysis has several strengths. Physical 
activity and sedentary time were measured using 
accelerometry, and all individual participant data 
were reanalysed in a harmonised manner. Device 
based measures of sedentary time and physical 
activity are less prone to biases usually associated with 
self report. However, interpreting associations with 
physical activity assessed by devices across studies is 
challenging because of variations in processing data 
collected from devices. Our harmonised approach 
substantially reduced heterogeneity among studies 
by applying a common and standardised definition 
of wear time, inclusion criteria, and definitions of 
thresholds for physical activity intensity and sedentary 
time. Furthermore, the large sample size allowed 
meta-analyses of the dose-response relations between 
various intensities of physical activity, including 
low and high light, and all cause mortality, as well 
as providing more precise results with narrower 
confidence intervals than in previous studies. Finally, 
we defined the absolute amount of time associated 
with maximal risk reduction for all cause mortality 
for different levels of physical activity intensity and 
identified a threshold for sedentary time where the risk 
of death increased more rapidly, based on the shape of 
the curve for the dose-response association.
This study also has some limitations. All studies 
were conducted in the US and western Europe 
limiting generalisability beyond these populations. 
All study data were analysed with men and women 
combined and after adjustment for sex. Thus we 
cannot exclude different associations between sexes; 
however, the results from the two studies of men and 
women separately12 37 are in agreement, suggesting 
the observed associations are similar. Residual 
confounding might exist, although the studies 
adjusted their analyses for several covariates (often 
including pre-existing illness, mobility limitations; 
all studies adjusted for smoking) in the final model 
and results were similar to those from the primary 
model, including sex, age, BMI, socioeconomic 
status, and wear time. We attempted to minimise bias 
from reverse causation by excluding all deaths within 
the first two years in sensitivity analyses. The hazard 
ratios were materially unchanged for the associations 
of total physical activity and light intensity or 
moderate-to-vigorous intensity physical activity 
with mortality, and slightly attenuated for sedentary 
time. However, bias from reverse causation might 
persist.38 All studies in our analysis included middle 
aged and older adults who were at least 40 years old; 
it is unclear whether the estimates of the absolute 
physical activity levels associated with maximal risk 
reduction apply to younger people. For the purposes 
of harmonisation, only data recorded from a single 
(vertical) axis were analysed; this tends to detect less 
time in light and moderate intensity activity and more 
time being sedentary compared with data recorded 
from three axes of newer generation devices.39 
table 2 | Meta-analysis for associations between total physical activity, intensities of physical activity or sedentary time by quarters and all cause 
mortality
variables
Hazard ratios (95% ci) for all cause mortality*; no of participants; no of deaths
First quarter  
(least active) second quarter third quarter
Fourth quarter  
(most active)
Model a
Total physical activity (cpm) 1 (ref) (n=9189; 1301) 0.47 (0.42 to 0.53) (n=9225; 506) 0.35 (0.26 to 0.47) (n=9207; 277) 0.28 (0.22 to 0.34) (n=9231; 220)
Physical activity intensity:
 Light (min/d) 1 (ref) (n=9191; 1188) 0.58 (0.52 to 0.64) (n=9214; 547) 0.42 (0.36 to 0.43) (n=9212; 332) 0.36 (0.28 to 0.46) (n=9235; 237)
 Low light (min/d) 1 (ref) (n=9182; 1100) 0.64 (0.57 to 0.72) (n=9224; 552) 0.46 (0.38 to 0.56) (n=9229; 376) 0.41 (0.35 to 0.50) (n=9217; 276)
 High light (min/d) 1 (ref) (n=9166; 1261) 0.53 (0.47 to 0.60) (n=9241; 517) 0.36 (0.31 to 0.42) (n=9207; 290) 0.36 (0.25 to 0.51) (n=9227; 236)
 Moderate to vigorous (min/d) 1 (ref) (n=9095; 1221) 0.54 (0.48 to 0.60) (n=9296; 525) 0.40 (0.29 to 0.56) (n=9235; 311) 0.35 (0.28 to 0.44) (n=9226; 247)
 Sedentary (min/d) 1 (ref) (n=9219; 339) 1.32 (1.14 to 1.54) (n=9223; 432) 1.97 (1.69 to 2.30) (n=9201; 598) 3.22 (2.49 to 4.15) (n=9190; 935)
Model b†
Total physical activity (cpm) 1 (ref) (n=9096; 1187) 0.48 (0.43 to 0.54) (n=9105, 483) 0.34 (0.26 to 0.45) (n=9096, 265) 0.27 (0.23 to 0.32) (n=9086, 214)
Physical activity intensity:
 Light (min/d) 1 (ref) (n=9073; 1089) 0.60 (0.54 to 0.68) (n=9101; 511) 0.44 (0.38 to 0.51) (n=9090; 320) 0.38 (0.28 to 0.51) (n=9119; 229)
 Low light (min/d) 1 (ref) (n=9066; 1010) 0.66 (0.56 to 0.77) (n=9106; 518) 0.47 (0.38 to 0.58) (n=9112; 353) 0.42 (0.34 to 0.52) (n=9099; 268)
 High light (min/d) 1 (ref) (n=9054; 1159) 0.55 (0.49 to 0.63) (n=9120; 483) 0.38 (0.30 to 0.48) (n=9088; 278) 0.37 (0.32 to 0.46) (n=9113; 229)
 Moderate to vigorous (min/d) 1 (ref) (n=9002; 1139) 0.64 (0.55 to 0.74) (n=9153; 468) 0.55 (0.40 to 0.74) (n=9123; 305) 0.52 (0.43 to 0.61) (n=9105; 237)
 Sedentary (min/d) 1 (ref) (n=9102; 327) 1.28 (1.09 to 1.51) n=9105; 417) 1.71 (1.36 to 2.15) (n=9096; 562) 2.63 (1.94 to 3.56) (n=9080; 843)
Model c†
Total physical activity (cpm) 1 (ref) (n=8971; 1122) 0.54 (0.48 to 0.61) (n=9004; 458) 0.41 (0.32 to 0.51) (n=8972; 259) 0.34 (0.29 to 0.41) (n=8985; 208)
Physical activity intensity:
 Light (min/d) 1 (ref) (n=8944; 1030) 0.66 (0.58 to 0.74) (n=8979; 485) 0.51 (0.44 to 0.57) (n=8992; 308) 0.44 (0.34 to 0.59) (n=9017; 224)
 Low light (min/d) 1 (ref) (n=8939; 959) 0.70 (0.62 to 0.79) (n=8997; 490) 0.54 (0.48 to 0.63) (n=8999; 338) 0.48 (0.40 to 0.57) (n=8997; 260)
 High light (min/d) 1 (ref) (n=8919; 1086) 0.63 (0.56 to 0.71) (n=8990; 467) 0.46 (0.39 to 0.54) (n=8985; 269) 0.45 (0.31 to 0.65) (n=9028; 225)
 Moderate to vigorous (min/d) 1 (ref) (n=8875; 1077) 0.69 (0.58 to 0.81) (n=9041; 441) 0.62 (0.48 to 0.80) (n=9009; 297) 0.61 (0.50 to 0.75) (n=9007; 232)
 Sedentary (min/d) 1 (ref) (n=9001; 317) 1.21 (1.02 to 1.42) (n=9006; 403) 1.56 (1.24 to 1.98) (n=8969; 536) 2.18 (1.61 to 2.95) (n=8956; 791)
cpm=counts per minute.
Model A adjusted for sex (when applicable), age, and wear time (n=36852, 2304 deaths). Model B adjusted for sex (when applicable), age, body mass index, socioeconomic position, and wear 
time (n=36383, 2149 deaths). Model C additionally adjusted for covariates listed in table 1 (n=35 932, 2047 deaths).
*By Cox regression.
†Moderate-to-vigorous physical activity and sedentary time are mutually adjusted.
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Intensity thresholds are influenced by participant 
age and activities included in any calibration study 
and there is currently no consensus about standard 
intensity thresholds. We used thresholds derived 
during locomotor activities (ie, walking and jogging) 
in young adults when defining time spent in light, 
moderate, and vigorous physical activity,25 that 
are higher than those derived in older women in a 
range of activities, including sitting and standing.40 
This could affect the absolute time spent in vigorous 
physical activity and in prolonged bouts of moderate-
to-vigorous physical activity. Furthermore, results 
were combined from studies using two different 
brands of accelerometers; however, when we 
restricted analyses to the six studies using the same 
accelerometer brand, similar findings were observed. 
Risk of bias was assessed using the Newcastle-
Ottawa scale suggested as an alternative to the Risk 
of Bias in Non-randomised Studies of Interventions.41 
Finally, physical activity and sedentary time were 
only measured once, therefore changes in these 
behaviours might affect the observed associations.
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Fig 2 | Dose-response associations between total physical activity (top left), light intensity physical activity (lPa) (top right), low lPa (middle left), 
high lPa (middle right), moderate-to-vigorous intensity physical activity (MvPa) (bottom left), and sedentary time (bottom right, data from regarDs 
(reasons for geographic and racial Differences in stroke)9 and FHs (women’s Health study)12 are only included for MvPa) and all cause mortality. 
Modelling performed using restricted cubic splines with knots at 25th, 50th, and 75th centiles of exposure specific distribution from medians of 
quarters (least to most active). the exposure reference is set as the median of the medians in the reference group (least active) (see supplementary 
table 3). Knot locations are available in supplementary table 8. cpm=counts per minute
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comparison with other studies
Higher levels of total physical activity, which combine 
the frequency, duration, and intensity of activity, were 
associated with a substantially reduced risk of death 
in a dose-response fashion. In spline analyses, the 
maximal risk reduction was observed at about 300 
counts per minutes (cpm, fig 2, supplementary table 5). 
This value mirrors the median total physical activity for 
the third quarter across studies (supplementary table 
3). It is also similar to the mean value observed in US 
men, between 10-15% higher than in US women and 
about 10-15% lower than in the population based 
samples from Norway and Sweden (supplementary 
table 1). The amount of total physical activity required 
for maximal risk reduction thus seems achievable for 
large segments of the population. For those unable 
to accumulate this amount, it is encouraging to note 
that the largest risk reduction was observed between 
the second quarter and the referent (least active). The 
observed magnitude of risk reduction (about 60-70%) 
is more than twice as large as previously reported from 
studies assessing total physical activity by self report.42 
Our findings extend previous observations from 
individual studies on device assessed total physical 
activity10 12 and those reported for total physical 
activity in community dwelling elderly people,43 44 by 
reducing the uncertainty in the effect estimates in a 
much larger and more heterogeneous sample.
Our results also suggest substantial risk reductions 
from light intensity physical activity, in a dose-
response fashion. A recent meta-analysis45 that 
combined self reported and device based measures 
of light intensity physical activity observed a pooled 
risk reduction of 29% when extreme groups were 
compared, smaller in magnitude than the estimate 
reported here (about 60% when the fourth quarter 
was compared with the referent). Time accumulated 
in moderate-to-vigorous intensity physical activity was 
also associated with reduced mortality risk in a dose-
response manner. It should be noted, however, that the 
definition of intensity1 46 is based on absolute intensity 
(ie, as customary, light intensity=1.5-2.9 metabolic 
equivalents of task (METs); moderate-to-vigorous 
intensity ≥3 METs). In older people, who constitute 
most of the participants in our meta-analysis, maximal 
cardiorespiratory fitness may not exceed 6 or 7 METs.47 
Thus high light intensity physical activity as defined 
in the present analyses might actually represent 
moderate-to-vigorous intensity physical activity, 
relative to the fitness level of these older adults. Future 
calibration studies aimed at identifying intensity 
thresholds for light and moderate intensity physical 
activity from tri-axial accelerometry based on relative 
intensity (ie, % maximal cardiorespiratory fitness) 
are needed, especially for use in older populations. 
Owing to the low numbers of people with high levels of 
time spent in moderate-to-vigorous intensity physical 
activity, wide confidence intervals were observed 
at this part of the dose-response curve warranting 
cautious interpretation. The maximal risk reduction 
was seen at about 24 min/day, congruent with the 
minimum recommended level of physical activity for 
Americans46 and the proposed draft of the new UK 
physical activity guidelines48 of at least 150 minutes of 
moderate intensity physical activity each week. Similar 
to total physical activity and light intensity physical 
activity, the maximal risk reduction observed for 
moderate-to-vigorous physical activity (about 60%), is 
about twice the magnitude as previously reported in a 
meta-analysis, where physical activity was assessed by 
self report.49 We observed smaller magnitudes of risk 
reduction for bouts of moderate-to-vigorous intensity 
physical activity and vigorous intensity physical 
activity compared with the other physical activity 
exposure variables. Most participants, however, 
did not record any minutes at these intensity levels, 
limiting the interpretation of these observations.
Higher sedentary time was positively associated 
with higher risk of death, and the risk increased at 
levels greater than 9.5 hours each day. This estimate is 
higher than a proposed threshold of 6 to 8 hours each 
day identified in a recent meta-analysis examining the 
association between primarily self reported sitting time 
and mortality.5 Given the strong association between 
total physical activity and mortality, it is plausible that 
findings for sedentary time reflect the “flip side” of a 
coin.50
implications and future research
Recent national51 and international52 strategies to 
improve public health through physical activity in 
populations are supported by our results. Additionally, 
these results reinforce the new physical activity 
recommendations for Americans to limit sedentary time 
and that moderate-to-vigorous intensity physical activity 
need not occur in 10 minute bouts.46 Furthermore, the 
findings are important for policymakers and can inform 
future guideline development by also recognising the 
role of light intensity physical activity and hence total 
physical activity for reducing the risk of premature 
death. Thus, the public health message might simply be 
“sit less and move more and more often.”
We only investigated associations with all cause 
mortality. Thus more work is needed to determine 
the associations between physical activity and 
sedentary time with cause specific mortality and for 
other chronic morbidities such as type 2 diabetes, 
which may manifest at a younger age than the age of 
our cohorts. Future studies using repeated measures 
of physical activity with device based methods such 
as acclerometry are also needed to examining the 
associations between changes in physical activity 
and sedentary time with clinical health outcomes. 
Finally, data on the association between device based 
assessment of physical activity and mortality from low 
and middle income countries are currently unavailable.
conclusion
Our findings provide clear scientific evidence that 
higher levels of total physical activity—regardless of 
intensity level—and lesser amounts of sedentary time 
are associated with lower risk for premature mortality, 
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with evidence of non-linear, dose-response patterns in 
middle aged and older people.
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